2. Why Should You Want To?
• NRF rating panels now make use of h-indices
calculated via both ISI Web of Science AND
Scopus
• Ad Hominem Promotions Committees at UCT
look at publication numbers and citations
• Knowing relative impacts in a field can be useful
in rating other people objectively
• Departmental / Unit / Group reviews can be
informed wrt numbers of papers, impacts
• Patents are an important part of your
publications and achievements for assessment –
and UCT keeps careful track of these
7. Autogoogling 2
To start with:
• Need a Gmail address for sign-in
• Need to train GSC as to which are your papers
What you can do:
• Immediately see your Hirsch or h-index* (which is
usually significantly higher than the Scopus or ISI
measure)
• See your 5-year h-index&, which is a good measure or
your (or other person's) recent impact
*h-index is the largest number h such that h publications have at least h citations
& largest number h such that h publications have at least h new citations in the last 5 years.
11. Harzing’s P or P
Publish or Perish is a software program that retrieves and analyzes academic
citations. It uses Google Scholar to obtain the raw citations, then analyzes these
for:
• Total number of papers Google Scholar / H or H might
• Total number of citations be best for:
• Average number of citations per paper • Business, Administration,
• Average number of citations per author
• Average number of papers per author Finance & Economics;
• Average number of citations per year • Engineering, Computer
• Hirsch's h-index and related parameters Science & Mathematics;
• Egghe's g-index
• The contemporary h-index • Social Sciences, Arts &
• The age-weighted citation rate Humanities.
• Two variations of individual h-indices
• An analysis of the number of authors per paper.
The results are available on-screen and can also be copied to the Windows clipboard (for
pasting into other applications) or saved
Training resources
A 15-minute audio & slide presentation on citation analysis and Publish or Perish can be
found on Slideshare.
21. UCT patent info from RCIPS
Research Contracts and Intellectual Property Services
Department of Research and Innovation
2 Rhodes Avenue (Corner Main Road)
Mowbray
7701
Sample of printout from
Email: Innovation@uct.ac.za database kept by RCIPS for
Tel: +2721 650 4015
Reception:+2721 650 4015
each UCT inventor
Date: 15 October 2012
Patent Portfolio
Inventor: E.P. Rybicki
*Address 34 Uitvlugt Road, Pinelands Nationality: South African
7405
Department: Molecular & Cell
Ed. Rybicki@ gmail.com Biology, Dept of
*Please Advise RCIPS, of any changes to your details
Status Definitions:
22. Patent records
Patent Family: HIV DNA Vector Patent Expression System Incorporating a
Family Title: Capsid
Promoter Sequence as an Enhancer of
a Cytomegalovirus Promoter
Complete List of Inventors: Rybicki E.P., Tanzer F.L.
Concise listing of inventors, claims, etc
Patent
The amended claim set for Entry into National Phase covers the following:
Description :
- A method for enhancing expression of a transgene from the CMV promoter using a sequence of a
capsid promoter (Pcap) element or a reverse complement thereof (PcapR) which is at least 80%
identical to any one of the following sequences: 184 bp Pcap and PcapR fragments from PCV-1;
equivalent regions from the canary, goose, duck, columbid, gull, and finch circoviruses, BFDV and
PCV-2; linearized PCV-1 and its reverse complement; and PCV-1 Prep with deletion of the
Rep/Rep’ protein binding sites and 5’ truncated rep gene. The capsid promoter element or reverse
complement thereof can be inserted immediately upstream (5’) of the CMV promoter or up to 1100
bp upstream of it.
- The above method wherein the capsid promoter element or reverse complement thereof is from a
parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or
torque teno mini virus).
- The expression cassette itself (Pcap element + CMV promoter)
- A vector including the expression cassette
- A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as
23. - The above method wherein the capsid promoter element or reverse complement thereof is from a
Patent records
parvovirus (specifically canine parvovirus) or an anellovirus (specifically a torque teno virus or
torque teno mini virus).
- The expression cassette itself (Pcap element + CMV promoter)
- A vector including the expression cassette
- A DNA vaccine or pharmaceutical composition including the expression cassette or vector (as
well as methods of treating HIV/AIDS etc.)
Full list of countries where filed, status, grant numbers and vital dates
At the meeting in November 2007 to discuss the future of the SAAVI patents it was agreed that we
should proceed to national phase with this patent in the following countries: Europe, USA, ARIPO,
India, Namibia, SA and Brazil.
Application Region Application Application Status Grant Grant
Date Type Number Number Date
08-Nov-05 South Africa Provisional 2005/09036 closed 08-Nov-06
08-Nov-06 PCT PCT PCT/IB2006/003150 closed 07-May-08
08-May-08 Brazil National Phase PI0619665-9 Filed 08-May-08
08-May-08 ARIPO National Phase AP/P/2008/004476 Filed 08-May-08
08-May-08 India National Phase 4927/DELNP/2008 Filed 08-May-08
08-May-08 South Africa National Phase 2008/03928 Granted 2008/03928 30-Sep-09
08-May-08 United States National Phase 12/084,728 Filed 08-May-08
08-May-08 Europe National Phase 06820870.1 Filed 08-May-08
24. Further analysis of impact
• Deeper analysis of citations is possible using
proprietary software. This allows:
– Identification of multi/trans disciplinary groups
publishing on a common theme
– Assessment of impact of this work in terms of
leadership of the field internationally or at UCT
– Quick identification of international and local
collaborators (see http://www.slideshare.net/edrybicki/uct-
collaboration-2006-2010-res-indaba)
26. …so what does it do?
UCT Competencies: size
is proportional to
number of publications;
position and colours of
lines indicate
multidisciplinarity
(more towards middle)
34. How to use this for the NRF / Faculty
• NRF Assessment Biographical info (last 8 yrs):
“My publishing impact has increased significantly since 2003: I now
have 137 ISI-listed publications, a h-index of 25 and over 2200
citations, compared to a h-factor of 17, 70 publications and 783
citations in 2002.” My research group leads the world in a
Distinctive Competency identified by SciVal Spotlight…
• NRF Publications info: best research outputs
Motivation :
This article established that, unlike previous investigations, it was possible
to get high-level expression of HPV-16 L1 protein via transient expression
in plants, that it assembled into VLPs, and that it elicited neutralising
antibodies in mice. It has been cited 34 times…
• HR174 promotion / assessment info
My research group leads the world in a Distinctive Competency identified
by SciVal Spotlight…because of my group, UCT is top in the field of
geminivirus diversity / Jane Austen / bullfrogs….
35. How to do an institutional search
Institutional / Unit / Department Review
36.
37. Limit to last 5 years
Modify search query with advanced tools
40. How to use this for reviews
• Institutional address searches via Scopus (NOT
ISI!) allow easy retrieval of papers over a given
time period by people who would otherwise have
been missed (or forgotten)
• The impact of the publications can very simply be
assessed
• Cognate searches done on other Depts /
institutes can be done as easily for comparative
purposes: eg “we score as highly as the
Universities of Sydney / Auckland / Hyderabad…”